Related Experiment Video
Updated: May 25, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Continuous-flow left ventricular assist device support in patients with advanced heart failure: points of interest
S E A Felix1, J R Martina, J H Kirkels
1Department of Cardiology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht, The Netherlands.
Abstract:
Today, continuous-flow left ventricular assist devices (cf-LVADs) are implanted more often in patients with end-stage heart failure. Because of greater durability they can be implanted for an extended period of time. As a result of increased numbers of patients on cf-LVAD support, healthcare professionals should be aware of the potential complications inherent to this therapy. Both bleeding and thrombosis may occur, and also complications related either to the device itself or to the ensuing altered haemodynamics, valvular pathology, and rhythm disturbances such as ventricular tachycardias and fibrillation. Accurate clinical evaluation, together with an electrocardiogram and, if necessary, combined with an echocardiogram, is obligatory in these situations. This review summarizes common complications complemented by a few clinical cases.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Cardiomyopathy V: Interprofessional Care
Heart Failure VII: Nursing Interventions
Cardiomyopathy II: Dilated Cardiomyopathy
Mitral Stenosis IV: Nursing Management
